Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 433 participants.

Also called NCT01509937

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 433 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01509937
Other papers using this trial's data
  • The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients : Primary results of a randomized trial - BOdy COmposition MOnitor (BOCOMO) study BMC nephrology, 2020-04-15 DOI, PubMed 32295531, PMC7161118 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01509937. Randomized; no masking; primary purpose supportive care. Start 2013-01 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients
Acronym
BOCOMO
Condition
End Stage Renal Disease
Intervention (Device)
body bioimpedance spectroscopy device
Intervention (Device)
Device
Lead sponsor
Peking University First Hospital (class: other)
Collaborator
Fresenius Medical Care (Shanghai) Co., Ltd (class: not stated)

Record details

Record id
cardio:ct-nct01509937
Content hash
7f920a34549c2b00af1d0a9ead29eba36de4475e720e9e3b1d673c275bf45fde